 Fluticasone-Salmeterol Drug Combination
"Fluticasone-Salmeterol Drug Combination" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A drug combination of fluticasone and salmeterol that is used as an inhaler formulation to manage the symptoms of ASTHMA and CHRONIC OBSTRUCTIVE PULMONARY DISEASE.
| Descriptor ID |
D000068297
|
| MeSH Number(s) |
D02.033.100.291.057.750.500 D02.092.063.291.057.750.500 D02.092.471.683.061.750.500 D04.210.500.054.079.129.114.500 D26.310.438
|
| Concept/Terms |
Fluticasone-Salmeterol Drug Combination- Fluticasone-Salmeterol Drug Combination
- Drug Combination, Fluticasone-Salmeterol
- Fluticasone Salmeterol Drug Combination
- Fluticasone - Salmeterol
- Fluticasone Salmeterol
- Fluticasone-Salmeterol Combination
- Combination, Fluticasone-Salmeterol
- Fluticasone Salmeterol Combination
Fluticasone Propionate, Salmeterol Xinafoate Drug Combination- Fluticasone Propionate, Salmeterol Xinafoate Drug Combination
- Fluticasone Propionate-Salmeterol Xinafoate Combination
- Fluticasone Propionate Salmeterol Xinafoate Combination
- Fluticasone Propionate-Salmeterol Drug Combination
- Fluticasone Propionate Salmeterol Drug Combination
- Fluticasone Propionate - Salmeterol Combination
- Fluticasone Propionate Salmeterol Combination
- Fluticasone Propionate-Salmeterol Xinafoate Drug Combination
- Fluticasone Propionate Salmeterol Xinafoate Drug Combination
- Fluticasone Propionate - Salmeterol Xinafoate
- Fluticasone Propionate Salmeterol Xinafoate
- Fluticasone Propionate - Salmeterol
- Fluticasone Propionate Salmeterol
|
Below are MeSH descriptors whose meaning is more general than "Fluticasone-Salmeterol Drug Combination".
Below are MeSH descriptors whose meaning is more specific than "Fluticasone-Salmeterol Drug Combination".
This graph shows the total number of publications written about "Fluticasone-Salmeterol Drug Combination" by people in this website by year, and whether "Fluticasone-Salmeterol Drug Combination" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2008 | 0 | 1 | 1 | | 2010 | 0 | 2 | 2 | | 2011 | 0 | 1 | 1 | | 2012 | 0 | 1 | 1 | | 2013 | 0 | 1 | 1 | | 2014 | 0 | 1 | 1 | | 2016 | 2 | 0 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Fluticasone-Salmeterol Drug Combination" by people in Profiles.
-
Bender BG, Hernandez Vecino RA, McGrath K, Jones S. Comparative Analysis of Persistence to Treatment among Patients with Asthma or COPD Receiving AirFluSal Forspiro or Seretide Diskus Salmeterol/Fluticasone Propionate Combination Therapy. J Allergy Clin Immunol Pract. 2016 Sep-Oct; 4(5):884-9.
-
Stempel DA, Szefler SJ, Pedersen S, Zeiger RS, Yeakey AM, Lee LA, Liu AH, Mitchell H, Kral KM, Raphiou IH, Prillaman BA, Buaron KS, Yun Kirby S, Pascoe SJ. Safety of Adding Salmeterol to Fluticasone Propionate in Children with Asthma. N Engl J Med. 2016 09 01; 375(9):840-9.
-
Malka J, Mauger DT, Covar R, Rabinovitch N, Lemanske RF, Spahn JD, Strunk RC, Zeiger RS, Morgan WJ, Szefler SJ. Eczema and race as combined determinants for differential response to step-up asthma therapy. J Allergy Clin Immunol. 2014 Aug; 134(2):483-5.
-
Chang TS, Lemanske RF, Mauger DT, Fitzpatrick AM, Sorkness CA, Szefler SJ, Gangnon RE, Page CD, Jackson DJ. Childhood asthma clusters and response to therapy in clinical trials. J Allergy Clin Immunol. 2014 Feb; 133(2):363-9.
-
Stanford RH, Blanchette CM, Roberts MH, Petersen H, Fuhlbrigge AL. Effect of combination fluticasone propionate and salmeterol or inhaled corticosteroids on asthma-related outcomes in a Medicare-eligible population. Am J Geriatr Pharmacother. 2012 Dec; 10(6):343-51.
-
Horner CC, Mauger D, Strunk RC, Graber NJ, Lemanske RF, Sorkness CA, Szefler SJ, Zeiger RS, Taussig LM, Bacharier LB. Most nocturnal asthma symptoms occur outside of exacerbations and associate with morbidity. J Allergy Clin Immunol. 2011 Nov; 128(5):977-82.e1-2.
-
Katial RK, Bernstein D, Prazma CM, Lincourt WR, Stempel DA. Long-term treatment with fluticasone propionate/salmeterol via Diskus improves asthma control versus fluticasone propionate alone. Allergy Asthma Proc. 2011 Mar-Apr; 32(2):127-36.
-
Katial RK, Oppenheimer JJ, Ostrom NK, Mosnaim GS, Yancey SW, Waitkus-Edwards KR, Prillaman BA, Ortega HG. Adding montelukast to fluticasone propionate/salmeterol for control of asthma and seasonal allergic rhinitis. Allergy Asthma Proc. 2010 Jan-Feb; 31(1):68-75.
-
Stanford RH, Fuhlbrigge A, Riedel A, Rey GG, Stempel DA. An observational study of fixed dose combination fluticasone propionate/salmeterol or fluticasone propionate alone on asthma-related outcomes . Curr Med Res Opin. 2008 Nov; 24(11):3141-8.
-
Make B, Hanania NA, ZuWallack R, Kalberg C, Emmett A, Brown CP, Knobil K. The efficacy and safety of inhaled fluticasone propionate/salmeterol and ipratropium/albuterol for the treatment of chronic obstructive pulmonary disease: an eight-week, multicenter, randomized, double-blind, double-dummy, parallel-group study. Clin Ther. 2005 May; 27(5):531-42.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|